Flagship opens hub, plants roots in the UK as government aims to boost life science ecosystemnews2023-11-28T11:41:57+00:00November 28th, 2023|Endpoints News|
Injectable form of argenx drug Vyvgart fails PhIII study in autoimmune platelet diseasenews2023-11-28T07:19:31+00:00November 28th, 2023|Endpoints News|
RoslinCT to commercially manufacture CRISPR-edited therapy Casgevy after collab extension with Vertex, CRISPRnews2023-11-28T07:01:58+00:00November 28th, 2023|Endpoints News|
Aldeyra’s dry eye drug gets a rejection from the FDAnews2023-11-28T01:31:20+00:00November 28th, 2023|Endpoints News|
Acelyrin says CRO Fortrea made errors in trial of lead immunology drug izokibepnews2023-11-28T01:25:30+00:00November 28th, 2023|Endpoints News|
SpringWorks Therapeutics ready to launch newly-approved desmoid tumor treatment after three-month delaynews2023-11-28T00:11:31+00:00November 28th, 2023|Endpoints News|
European AI startup raises $24M for protein design software servicenews2023-11-28T00:01:03+00:00November 28th, 2023|Endpoints News|
House committee probes FTC disclosure of confidential info in reviewing Amgen-Horizon dealnews2023-11-27T20:39:30+00:00November 27th, 2023|Endpoints News|
Marks: FDA open to using single-arm studies for accelerated approval of rare disease gene therapiesnews2023-11-27T20:11:23+00:00November 27th, 2023|Endpoints News|
Marius aims to shake up typical thinking about testosterone in new campaignnews2023-11-27T20:04:21+00:00November 27th, 2023|Endpoints News|
